AI revenue compounds ~10x/year into hundreds of billions, so frontier-lab compute spend keeps scaling fast
AI will revolutionize robotics within ~1-2 years of reaching country-of-geniuses, unlocking trillions in robot revenue
If AI floods the trial-and-approval pipeline, clinical-trial execution becomes the scarce resource and CROs re-rate up.
US export controls on advanced chips to China will keep failing because chip-sale money overrides the policy